FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Philips Respironics, FDA Reach Consent Decree

Philips Respironics and FDA reach an agreement on the terms of a consent decree over the companys struggles to resolve issues surrounding its troubled...

latest-news-card-1
Human Drugs

Human Genome Editing Product Development Guide

FDA issues a guidance entitled Human Gene Therapy Products Incorporating Human Genome Editing.

latest-news-card-1
Human Drugs

Azurity Pharma Recalls 1 Lot of Zenzedi

Azurity Pharmaceuticals recalls one lot of narcolepsy drug Zenzedi CII (dextroamphetamine sulfate tablets, USP) 30 mg after a report was received that...

latest-news-card-1
Biologics

Merck Keytruda Data Positive in Bladder Cancer

Merck says data from its Phase 3 AMBASSADOR (A031501)/KEYNOTE-123 trial evaluating Keytruda (pembrolizumab) are favorable for the therapy as a potenti...

latest-news-card-1
Medical Devices

De Novo OK for Google Phone Thermometer

FDA grants Google a de novo marketing authorization for its new body temperature app on its latest Pixel 8 Pro smart phone.

latest-news-card-1
Human Drugs

Postmarketing Drug Surveillance Best Practices

FDA releases a document entitled Best Practices for FDA Staff in the Postmarketing Safety Surveillance of Human Drug and Biological Products.

latest-news-card-1
Medical Devices

FDA Should Identify AI Legislative Changes: GAO

A new GAO reports recommends that FDA identify and document specific changes to its statutory authorities that would enable it to best oversee artific...

latest-news-card-1
Human Drugs

ICH Guide on Analytical Procedure Development

The International Council for Harmonization releases a guidance entitled Q14 Guideline on Analytical Procedure Development.

latest-news-card-1
Human Drugs

Remote Regulatory Assessments Draft Guide

FDA makes available a revised draft guidance entitled Conducting Remote Regulatory Assessments (RRA) Questions and Answers.

latest-news-card-1
Federal Register

Vaccines/Biologics Advisory Committee Renewal

Federal Register notice: FDA announces the renewal of its Vaccines and Related Biological Products Advisory Committee for an additional two years.